Skip to main content
TipRanks
Go Ultimate75% OFF

Valeo Pharma (VPHIF) Q2 2024 Earnings Report

14 Followers

VPHIF Q2 2024 EPS Results

Actual EPS
-$0.06
Consensus EPS
-$0.03
Beat/Miss
Missed by -$0.02
One Year Ago EPS
-$0.06

VPHIF Q2 2024 Revenue Results

Actual Revenue
$9.88M
Expected Revenue
$10.83M
Beat/Miss
Missed by -$958.27K
YoY Revenue Growth
+4.21%

Earnings Announcement Details

Quarter
Q2 2024
Date
06/13/2024
Time
After Close
Conference Call
Thursday, June 13, 2024

Q2 2024 Earnings Call Audio

VPHIF Q2 2024 Earnings Call
0:00 / 0:00

Q2 2024 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2024 Earnings Call Summary

No earnings call summary is available for this earnings event.

VPHIF Earnings History

VPHIF earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Sep 10, 20252025 (Q3)―--0.06―
Jun 17, 20252025 (Q2)―--0.06―
Mar 27, 20252025 (Q1)―--0.06―
Feb 26, 20252024 (Q4)―-――
Sep 12, 20242024 (Q3)-0.03-0.06-0.05-18.57% (-0.01)
Jun 13, 20242024 (Q2)-0.03-0.06-0.060.00% (+0.00)
Mar 14, 20242024 (Q1)-0.05-0.06-0.060.00% (+0.00)
Jan 29, 20242023 (Q4)-0.04-0.07-0.089.09% (+0.01)
Sep 13, 20232023 (Q3)-0.04-0.05-0.04-16.67% (-0.01)
Jun 13, 20232023 (Q2)-0.05-0.06-0.04-33.33% (-0.01)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed